歯科薬物療法
Online ISSN : 1884-4928
Print ISSN : 0288-1012
ISSN-L : 0288-1012
口腔癌治療時に汎用される院内製剤アズノール含嗽水の安定性と細菌学的検討
牛山 美奈池田 龍二新田 哲也田實 裕介宮脇 昭彦山口 辰哉下堂薗 権洋牛之濱 風見松井 竜太郎杉原 一正中村 典史山田 勝士
著者情報
ジャーナル フリー

2008 年 27 巻 3 号 p. 143-150

詳細
抄録

In our hospital, hospital preparations of Azunol Saline Gargle (AS, saline solution containing 0.006% sodium gualenate hydrate), and Azunol Lidocaine Saline Gargle (ALS, AS with lidocaine) are used as a treatment for oral cancer with oral mucositis. However, little is known about the stability and microbiological safety of AS and ALS. In this study, the stability and microbiological safety of AS and ALS were assessed as the pH and the percent of sodium gualenate hydrate remaining in both preparations after exposure to various light and temperature conditions and the colony formation, respectively. As a result, we found that under fluorescent lamp lighting, AS and ALS were stable for 7 days at 4°C compared with 25t or room temperature. Furthermore, by light shielding, they were stable for at least 14 days at 4°C. Bacterial contamination of AS was prevented by preserving at 4°C for 14 days.
We have demonstrated the stability and microbiological safety of AS and ALS and established an appropriate preservation method. This study provides useful information regarding the management of oral mucositis in oral cancer patients.

著者関連情報
© 日本歯科薬物療法学会
次の記事
feedback
Top